Akèy › Skleroz Miltip › Illinois › Chicago
Etid klinik pou Skleroz Miltip nan Chicago, IL
15 etid pou Skleroz Miltip ap chèche patisipan nan sit nan ak bò kote Chicago (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Ap rekriteEtid obsèvasyon
- TG Therapeutics Investigational Trial Site, Chicago
- TG Therapeutics Investigational Trial Site, Chicago
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Ap rekriteFaz 2
- Rush University Medical Center, Chicago
- University of Chicago Medical Center, Chicago
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
Ap rekriteFaz 3
- University of Chicago Medical Center, Chicago
Evaluation of the Safety and Efficacy of a Full-Body Electrostimulation Garment for Individuals With Neurological and Neuromuscular Conditions That Cause Spasticity, Hyperreflexia, and Pain
Ap rekrite
- Shirley Ryan AbilityLab, Chicago
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Ap rekriteFaz 3
- Northwestern Memorial Hospital, Chicago
Ocrevus Zunovo for MS: Mixed Methods
Ap rekriteEtid obsèvasyon
- Northwestern Memorial Hospital, Chicago
Exercise Rehabilitation Program in MS Who Use Wheelchairs as a Primary Mobility Device
Ap rekrite
- University of Illinois at Chicago, Chicago
Functional Balance Intervention in Multiple Sclerosis
Ap rekrite
- University of Illinois at Chicago, Chicago
Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
Ap rekrite
- University of Illinois at Chicago, Chicago
Nomad P-KAFO Study
Ap rekrite
- Shirley Ryan AbilityLab, Chicago
Intermittent Hypoxia in Persons With Multiple Sclerosis
Ap rekrite
- Shirley Ryan AbilityLab, Chicago
Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis
Ap rekriteFaz 4
- Northwestern Memorial Hospital, Chicago
People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists
Ap rekriteEtid obsèvasyon
- Northwestern Memorial Hospital, Chicago
Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS
Ap rekrite
- Shirley Ryan AbilityLab, Chicago
Home Based Functional Balance Intervention for Multiple Sclerosis
Ap rekrite
- University of Illinois at Chicago, Chicago
Etid Skleroz Miltip nan lòt vil
- New York City, NY17 etid
- Boston, MA14 etid
- Washington, DC13 etid
- Cleveland, OH9 etid
- St. Louis, MO8 etid
- San Francisco, CA8 etid
- Kansas City, KS8 etid
- Birmingham, AL8 etid
- Baltimore, MD7 etid
- Aurora, CO7 etid
- Columbus, OH7 etid
- Seattle, WA7 etid
Lòt etid nan Chicago
- Kansè Poumon ki pa ti selil61 etid
- Kansè nan tete58 etid
- Kansè (tout kalite)52 etid
- Kansè Metastatik45 etid
- Kansè pwostat45 etid
- Obèsite42 etid
- Kansè poumon41 etid
- Kansè ovè36 etid
- Akidan serebavaskilè34 etid
- Ensifizyans kadyak32 etid
- Kansè kolorektal32 etid
- Sipwa28 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.